anti mouse cd8 α (Bio X Cell)
Structured Review
Anti Mouse Cd8 α, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 205 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd8/InVivoMAb+anti-mouse+CD8%CE%B2/pm42829916-411-4-19
Average 96 stars, based on 205 article reviews
Images
Related Articles
Injection:Article Title: IL-1R2 Deficiency Unleashes Neutrophil-Mediated Antitumor Potential in Sarcoma Article Snippet: Mice were injected intraperitoneally (i.p.) with 200 μg of specific monoclonal antibodies or inhibitors: anti-mouse CD8, InVivoPlus, clone YTS169.4 (BioXCell Cat. BP0117, RRID:AB_2894806) and the relative isotype control rat IgG2b, InVivoPlus, clone LTF-2 (BioXCell Cat. BP0090, RRID:AB_1107780); anti-mouse NK1.1, InVivoPlus, clone PK136 (BioXCell Cat. BP0036, RRID:AB_2894792) and the relative isotype control rat IgG2a, InVivoPlus, clone C1.18.4 (BioXCell Cat. BP0085, RRID:AB_1107771); anti-IFNInVivoPlus, clone XMG1.2 (BioXCell Cat. BP0055, RRID:AB_1107694) and the relative isotype control rat IgG1, InVivoPlus, clone HRPN (BioXCell Cat. BP0088, RRID:AB_1107775), the day before tumor cell transplantation. .. They were the injected i.p. with 100 μg once (anti-NK1.1), twice ( Control:Article Title: IL-1R2 Deficiency Unleashes Neutrophil-Mediated Antitumor Potential in Sarcoma Article Snippet: Mice were injected intraperitoneally (i.p.) with 200 μg of specific monoclonal antibodies or inhibitors: anti-mouse CD8, InVivoPlus, clone YTS169.4 (BioXCell Cat. BP0117, RRID:AB_2894806) and the relative isotype control rat IgG2b, InVivoPlus, clone LTF-2 (BioXCell Cat. BP0090, RRID:AB_1107780); anti-mouse NK1.1, InVivoPlus, clone PK136 (BioXCell Cat. BP0036, RRID:AB_2894792) and the relative isotype control rat IgG2a, InVivoPlus, clone C1.18.4 (BioXCell Cat. BP0085, RRID:AB_1107771); anti-IFNInVivoPlus, clone XMG1.2 (BioXCell Cat. BP0055, RRID:AB_1107694) and the relative isotype control rat IgG1, InVivoPlus, clone HRPN (BioXCell Cat. BP0088, RRID:AB_1107775), the day before tumor cell transplantation. .. They were the injected i.p. with 100 μg once (anti-NK1.1), twice ( Article Title: MERTK inhibition cooperates with immunomodulatory cyclophosphamide to induce CXCL9 + monocyte-macrophage programming and durable antitumor immunity in triple negative breast cancer Article Snippet: Control mice were injected i.p. with mouse IgG2a isotype (BioXCell, CP150, RRID:AB_2927524, RRID:AB_2927524) at 200μg every three days. .. For immune cell/signaling depletion/blockade studies mice were treated with 100 μL via i.p. injections with either anti-CD4 (BioXCell, BE0003–1, RRID:AB_1107636), anti-CXCR3 (BioXCell, BE0249, RRID:AB_2687730), other:Article Title: Potentiating dendritic cell immunotherapy by interrupting the Semaphorin 4D-induced immune-suppressive barrier. Article Snippet: The body temperature was maintained at 37 ◦ C with the aid of an MR-compatible Small Rodent Heater System (SAII, SA Instruments, Stony Brook, NY). |
